Pamidronate disodium

Modify Date: 2024-01-02 18:32:27

Pamidronate disodium Structure
Pamidronate disodium structure
Common Name Pamidronate disodium
CAS Number 57248-88-1 Molecular Weight 281.05
Density N/A Boiling Point N/A
Molecular Formula C3H11NNa2O7P2 Melting Point 300 °C
MSDS N/A Flash Point N/A

 Use of Pamidronate disodium


Pamidronate disodium, a bisphosphonate drug, can help to strengthen bones.Target: OthersPamidronate belongs to the family of medications known as bisphosphonates. It is used to treat hypercalcemia (high blood calcium) by people who have cancer. Pamidronate is also used to treat cancer that has spread to bones (bone metastases) due to different types of tumours and multiple myeloma (cancer of the bone marrow). Pamidronate is also used to treat the symptoms of Paget's disease of bone.

 Names

Name Disodium Pamidronate Hydrate
Synonym More Synonyms

 Pamidronate disodium Biological Activity

Description Pamidronate disodium, a bisphosphonate drug, can help to strengthen bones.Target: OthersPamidronate belongs to the family of medications known as bisphosphonates. It is used to treat hypercalcemia (high blood calcium) by people who have cancer. Pamidronate is also used to treat cancer that has spread to bones (bone metastases) due to different types of tumours and multiple myeloma (cancer of the bone marrow). Pamidronate is also used to treat the symptoms of Paget's disease of bone.
Related Catalog
References

[1]. Zarychanski, R., et al., Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol, 2006. 81(1): p. 73-5.

 Chemical & Physical Properties

Melting Point 300 °C
Molecular Formula C3H11NNa2O7P2
Molecular Weight 281.05
PSA 186.59000
Appearance of Characters solid | white
Storage condition 2-8°C
Water Solubility H2O: 28 mg/mL

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SZ6525000
CHEMICAL NAME :
Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-, disodium salt
CAS REGISTRY NUMBER :
57248-88-1
LAST UPDATED :
199709
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C3-H9-N-O7-P2.2Na
MOLECULAR WEIGHT :
279.05

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
750 ug/kg/5D-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - visual field changes Sense Organs and Special Senses (Eye) - diplopia Sense Organs and Special Senses (Eye) - effect, not otherwise specified
REFERENCE :
ANZJB8 Australian and New Zealand Journal of Medicine. (Modern Medicine of Australia Pty., Ltd., 100 Pacific Highway, North Sydney, 2060, Australia) V.1- 1971- Volume(issue)/page/year: 24,320,1994
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
600 ug/kg/6H-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - changes in calcium
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 1,622,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
900 ug/kg
TOXIC EFFECTS :
Musculoskeletal - joints
REFERENCE :
APHRER Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26- 1992- Volume(issue)/page/year: 31,499,1997 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1740 mg/kg
SEX/DURATION :
female 15-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,654,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
60 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 42,654,1992

 Customs

HS Code 2931900090
Summary 2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%

 Synonyms

Disodium (3-amino-1-hydroxypropane-1,1-diyl)bis[hydrogen (phosphonate)]
Pamidronate disodium salt
Pamidronate disodium
Phosphonic acid, (3-amino-1-hydroxypropylidene)bis-, sodium salt (1:2)
Dinatrium-(3-amino-1-hydroxypropan-1,1-diyl)bis[hydrogen-(phosphonat)]
APD
Disodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate
MFCD01938386
EINECS 260-647-1
(3-amino-1-hydroxypropane-1,1-diyl)bis[hydrogène (phosphonate)] de disodium
Pamidronate (Disodium)
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Pamidronate disodium suppliers


Price: ¥282/250mg

Reference only. check more Pamidronate disodium price